| Literature DB >> 33681193 |
Binbin Hu1, Dingyue Zhang1, Kejia Zhao2, Yang Wang1, Lijiao Pei1, Qianmei Fu1, Xuelei Ma1.
Abstract
The deubiquitinating enzyme (DUB)-mediated cleavage of ubiquitin plays a critical role in balancing protein synthesis and degradation. Ubiquitin-specific protease 4 (USP4), a member of the largest subfamily of cysteine protease DUBs, removes monoubiquitinated and polyubiquitinated chains from its target proteins. USP4 contains a DUSP (domain in USP)-UBL (ubiquitin-like) domain and a UBL-insert catalytic domain, sharing a common domain organization with its paralogs USP11 and USP15. USP4 plays a critical role in multiple cellular and biological processes and is tightly regulated under normal physiological conditions. When its expression or activity is aberrant, USP4 is implicated in the progression of a wide range of pathologies, especially cancers. In this review, we comprehensively summarize the current knowledge of USP4 structure, biological functions, pathological roles, and cellular regulation, highlighting the importance of exploring effective therapeutic interventions to target USP4.Entities:
Keywords: NF-κB; USP4; cancer; deubiquitinase; inflammation
Year: 2021 PMID: 33681193 PMCID: PMC7935551 DOI: 10.3389/fcell.2021.595159
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X